Showing results (161-170 of 240) with videos related to

Sort By:
Pageof 24
The Journal of Biological Chemistry|September 25, 1989
Characterization of the binding of human tissue-type plasminogen activator to plateletsD E Vaughan, M E Mendelsohn, P J Declerck, et al.
Circulation Research|June 1, 1994
Methylene blue reverses endotoxin-induced hypotensionJ F Keaney, J C Puyana, S Francis, et al.
The American Journal of Cardiology|December 15, 1993
Usefulness and tolerability of hirulog, a direct thrombin-inhibitor, in unstable angina pectorisG V Sharma, D Lapsley, J A Vita, et al.
The Journal of Clinical Investigation|July 15, 1997
Nitric oxide released from activated platelets inhibits platelet recruitmentJ E Freedman, J Loscalzo, M R Barnard, et al.
Circulation|December 1, 1991
Thrombolytic therapy causes an increase in vascular permeability that is reversed by 1-deamino-8-D-vasopressinM A Rudd, M T Johnstone, L E Rabbani, et al.
Prostate Cancer and Prostatic Diseases|October 27, 2004
TGFBR1*6A is not associated with prostate cancer in men of European ancestryB K Suarez, P Pal, C H Jin, et al.
The Journal of Clinical Investigation|December 1, 1995
Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxideD S Marks, J A Vita, J D Folts, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitroB Gaston, J M Drazen, A Jansen, et al.
Circulation|December 1, 1990
Bleeding time prolongation with streptokinase and its reduction with 1-desamino-8-D-arginine vasopressinM T Johnstone, T Andrews, J A Ware, et al.
Circulation Research|June 26, 1999
Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII geneJ E Freedman, R Sauter, E M Battinelli, et al.
Pageof 24